At 38 years old, Jonathan Gluck was diagnosed with a rare form of cancer—and told he might have as little as 18 months to live. That was 22 years ago. Since then, he’s become something of an expert in dealing with high-stress ambiguity. Here’s his advice for dealing with the stress of waiting, whether it’s for potentially dire medical results or the outcome of a job interview.

The Health newsletter takes you inside what’s new in health, medicine and personal well-being. If you’re not subscribed, sign up here.

Doctors have long measured cholesterol levels to assess the risk of heart disease. Increasingly, people are also opting for a coronary artery calcium scan, or CAC, writes Sumathi Reddy. The simple, relatively affordable tests recently got a boost from influential clinical guidelines issued earlier this month by leading cardiology groups.

After years of refusing to embrace wearable fitness trackers, Pamela Paul discovered she’d already inadvertently succumbed—she had an iPhone and therefore a fitness app; its built-in ring was lying in wait. After first counting her steps, she was soon counting every other biometric—and, as she writes, wondering whether that was a good thing.

America’s costliest autism therapy provider will shut down in May, after Indiana banned the firm from billing Medicaid. WSJ reported on Piece by Piece Autism Centers last month in an article examining how some providers had outpaced regulators.

The American Heart Association clashed with RFK Jr. over red meat, dairy and beef tallow. The organization released new nutrition guidance that advises getting protein from plants rather than meat, contradicting dietary guidelines from the health secretary.

The founder of sexual-wellness startup OneTaste was sentenced to nine years in prison. Nicole Daedone was convicted of conspiracy to commit forced labor for allegedly exploiting employees and practitioners of her “orgasmic meditation” business. She plans to appeal.

How much analysts expect Eli Lilly’s once-daily pill for weight loss to generate in global sales by 2030, compared with $4 billion for the Wegovy pill, according to pharmaceutical commercial intelligence firm Evaluate. The pill, named Foundayo, got approval from U.S. drug regulators yesterday, kicking off a new front in the weight-loss drug wars.

• From protein chips to sex chocolate, what are “functional foods”—and do they actually boost health? (The Guardian)

• Seven things to know about the end of life, according to death doulas. (The Washington Post)

• There are more AI health tools than ever, but how well do they work? (MIT Technology Review)

The Health newsletter is your weekly guide to all the news that affects your health and well-being. This edition was curated and edited by Conor Grant—send him feedback or questions at conor.grant@wsj.com (if you’re reading this in your inbox, you can just hit reply). Got a tip for us? Here’s how to submit.